We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current JDHIF market cap is 9.97B. The company's latest EPS is CNY 0.6716 and P/E is 4.65.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 10.84B | 19.38B | 30.68B | 46.74B | 53.53B |
| Operating Income | 433.44M | 274.69M | -1.46B | -61.16M | 823.66M |
| Net Income | -971.81M | -17.23B | -1.07B | 380.11M | 2.14B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 8.68B | 43.99B | 48B | 61.28B | 64.29B |
| Total Liabilities | 9.14B | 4.74B | 8.15B | 16.49B | 14.92B |
| Total Equity | -459.03M | 39.25B | 39.85B | 44.78B | 49.37B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | 409.47M | 3.7B | 3.43B | 5.91B | 4.6B |
| Investing | -1.45B | -7.84B | -17.75B | -4.24B | -8.02B |
| Financing | 6.51B | 32.03B | -163.65M | -925.45M | -117.2M |
| Market Cap | 9.97B |
| Price to Earnings Ratio | 4.65 |
| Price to Sales Ratio | 0.19 |
| Price to Cash Ratio | 0.66 |
| Price to Book Ratio | 0.2 |
| Dividend Yield | - |
| Shares Outstanding | 3.19B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 100 |
| 52 Week Change | -49.68% |
| 52 Week High | 6.619 |
| 52 Week Low | 3.03 |
| Spread (Intraday) | 0.46 (15.28%) |
| Company Name | JD Health International Inc (PK) |
| Address |
po box 309 grand cayman KY1-1104 |
| Website | https://ir.jdhealth.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
